bioRxivMicrobiologyPreprint
Protein Targets of Inositol Pyrophosphate (5-IP7) in the parasite Trypanosoma cruzi
Abstract
Diphosphoinositol-5-pentakisphosphate (5-PP-P5), also known as inositol heptakisphosphate (5-IP7), has been described as a high-energy phosphate metabolite that participates in the regulation of multiple cellular processes through protein binding or serine pyrophosphorylation, a post-translational modification involving a {beta}-phosphoryl transfer. In this study, utilizing an immobilized 5-IP7 affinity reagent, we performed pull-down experiments coupled with mass spectrometry identification, and bioinformatic analysis, to reveal 5-IP7-regulated processes in the two proliferative stages of the unicellular parasite Trypanosoma cruzi. Our protein screen clearly defined two cohorts of putative targets either in the presence of magnesium ions or in metal-free conditions. The highest number of protein targets was detected in the absence of metal ions, with an overrepresentation of proteins involved in purine metabolism, protein phosphorylation, nucleosome assembly, cell redox homeostasis, parasite-surface components, and exocytosis, and only a 37% overlap between the two proliferative stages. In the presence of magnesium, there was a lower enrichment with the isolation of about 30 proteins with overrepresented candidates involved in tRNA amino acylation, phosphate homeostasis, lipid and glucose catabolism, and cell division, and 15% overlap between proliferative stages. To validate the pull-down results, we endogenously tagged four protein candidates and immunopurified them. Among the most interesting targets, we identified a choline/o-acetyltransferase domain-containing phosphoprotein that undergoes 5-IP7-mediated phosphorylation events at a polyserine tract (Ser578-580). We also identified a novel SPX domain-containing phosphoribosyl transferase [EC 2.7.6.1] herein termed as TcPRPS4. Our data revealed new functional roles of 5-IP7 in this divergent eukaryote, and provided potential new targets for chemotherapy.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced levels of inositol hexakisphosphate kinase (IP6K) impair life-cycle transitions and the intracellular development of Trypanosoma cruzi within human cardiomyocytes
Bryan E. Abuchery, Thaíse Lara Teixeira, … Marcelo S. da Silva·bioRxiv·May 29, 2026
- Anti-trypanosomal activity and target validation of the M17 leucyl-aminopeptidase inhibitor DDD00057570 in Trypanosoma cruzi
Mirtha Aguado, Janaina Ferreira do Nascimento, … Ariel Mariano Silber·bioRxiv·Oct 13, 2026
- Non-histone protein methylation in Trypanosoma cruzi epimastigotes
Rafael Fogaça de Almeida, Aline Castro Rodrigues Lucena, … Lyris Martins Franco de Godoy·PROTEOMICSPeer-reviewed·May 14, 2023
- Intracellular cyclic AMP levels modulate differential adaptive responses on epimastigotes and cell culture trypomastigotes of Trypanosoma cruzi
Tamara Sternlieb, Alejandra C. Schoijet, G. Alonso·Acta TropicaPeer-reviewed·Nov 14, 2019
- From Proteome Mining to Structural Validation: Phosphopyruvate Hydratase as a Structurally Tractable Drug Target in Kinetoplastid Parasites
Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, … Miguel Á. Chávez‐Fumagalli·bioRxiv·Jun 12, 2026
- Endogenous sterol synthesis is dispensable for Trypanosoma cruzi epimastigote growth but not stress tolerance
P. Dumoulin, J. Vollrath, … B. A. Burleigh·bioRxiv·May 3, 2022